II. Epidemiology
- Represent <1% of Pericarditis cases in Western Europe and U.S.
- Represents <5% of cases worldwide (except for Tuberculous Pericarditis)
- Non-Tuberculous Bacterial Causes are Uncommon
- Most Pericarditis cases are instead viral induced and inflammatory (see Pericarditis Causes)
III. Causes
- Seeding of Pericardium
- Direct spread from thoracic infection (e.g. empyema)
- Endocarditis with paravalvular abscess
- Hematogenous spread (Trauma, procedures)
- Organisms
- Coxiella Burnetii (most common of the nontuberculous purulent causes)
- Borelia Burgdorferi (most common of the nontuberculous purulent causes)
- Staphylococcus aureus (high mortality)
- Empyema with direct spread or hematogenous spread in children
- Streptococcus Pneumoniae
- More common prior to current Immunizations in U.S.
- HaemophilusInfluenzae
- More common prior to current Immunizations in U.S.
- Mycobacterium tuberculosis (mortality approaches 85% for untreated cases)
- See Tuberculous Pericarditis
- Most common cause in developing countries
- Salmonella
- Meningococcus
- Syphilis
- Whipple Disease
- Rickettsia
IV. Findings
- See Pericarditis
- Ill or septic appearing, febrile patients
V. Differential Diagnosis
VI. Diagnosis
- Pericardiocentesis for Gram Stain and culture
VII. Management
- See Pericarditis
- Purulent Bacterial Pericarditis
- Typically empiric Antibiotics, then guided by Pericardiocentesis fluid culture and sensitivity
- First-line Antibiotics
- Vancomycin 15-20 mg/kg IV every 8-12 hours AND
- Ceftriaxone 2 g IV every 24 hours OR Cefepime 2 g IV every 12 hours
- Alternative regimen
- Vancomycin 15-20 mg/kg IV every 8-12 hours AND
- Ciprofloxacin 750 mg orally twice daily OR 400 mg IV twice daily
-
Tuberculous Pericarditis
- Most common cause of Pericarditis in developing world (esp. with HIV Infection)
- See Tuberculous Pericarditis
- See Active Tuberculosis Treatment
- Interventions
- During Pericardiocentesis, irrigation and Fibrinolytic agent instillation within Pericardium may be considered
- Pericardial window may be needed in some cases
VIII. Prognosis
- Associated with worse prognosis than typical idiopathic or Viral Pericarditis
IX. References
- (2016) Sanford Guide, accessed 4/8/2016
- Klasek and Alblaihed (2023) Crit Dec Emerg Med 37(6): 4-11
- Pankuweit (2005) Am J Cardiovasc Drugs 5(2): 103-12 [PubMed]